Autism Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Autism Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2009-12-14Clinical Trial Update: Effect of Cognitive Behavioural Therapy (CBT) for Children With Autistic Spectrum Disorders [EARLY_Phase 1]
Clinical trial update on the effects of Cognitive Behavioral Therapy for children with autism spectrum disorder and anxiety, in an early-pha…
-
FDA approval · 2009-12-02FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves a supplemental application for a generic risperidone version manufactured by Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS withdrawal · 2009-10-02Clinical Trial Update: Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism
Clinical trial evaluating digital EEG spectral analysis to assess neuroelectrical processing abnormalities in autism has been withdrawn; the…
-
FDA approval · 2009-09-04FDA Approved: RISPERIDONE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for risperidone, a generic antipsychotic, authorizing its manufacturing and mar…
-
FDA approval · 2009-08-24FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
FDA approved a supplemental application for risperidone by Amici Pharma, Inc., signaling a labeling update or additional indication for the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-08-11Clinical Trial Update: Early Intervention Program for Children With Autism (BCRI Model) [NA]
This document is a clinical trial update about an early intervention program for children with autism (BCRI Model) led by Sun Yat-sen Univer…
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Effects of Hyperbaric Oxygen Therapy on Children With Autism [Phase 1]
A Phase 1 trial assessing hyperbaric oxygen therapy in children with autism has completed, reporting safety and preliminary effects.
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: A Pilot Trial of a Developmental, Individual-Difference, Relationship-Bases (DIR)/Floortime for Children With Autistic Spectrum Disorders [NA]
A completed pilot clinical trial evaluating DIR/Floortime, a developmental, individual-difference, relationship-based intervention, for chil…
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders [NA]
This trial update reports on the completion of a study evaluating methylphenidate for children and adolescents with pervasive developmental …
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD) [Phase 3]
A Phase 3 trial evaluating aripiprazole for behavioral symptoms in children and adolescents with autism completed, with results posted in Ju…
-
FDA approval · 2009-07-19FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-TAB (risperidone) from Janssen Pharmaceuticals. The notice lists the submission stat…
-
CLINICAL_TRIALS research · 2009-07-09Clinical Trial Update: Study of Fluconazole in Children With Autism Spectrum Disorder [NA]
Clinical trial update on fluconazole use in children with autism spectrum disorder; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder [Phase 4]
A Phase 4 trial comparing atomoxetine to placebo for ADHD symptoms in children and adolescents with autism spectrum disorder; results were p…
-
FDA approval · 2009-06-17FDA Approved: RISPERIDONE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's original ANDA for risperidone, authorizing a generic version of the antipsychotic.
-
CLINICAL_TRIALS trial_result · 2009-05-05Clinical Trial Update: Effects of Hyperbaric Oxygenation Therapy on Adaptive, Aberrant and Stereotyped Behaviors in Children With Autism [NA]
Clinical trial update on hyperbaric oxygen therapy for adaptive, aberrant, and stereotyped behaviors in children with autism; current study …
-
FDA approval · 2009-04-30FDA Approved: RISPERIDONE — Original Application (Par Health USA, LLC)
FDA approves Par Health USA, LLC's original application for a generic risperidone product, expanding access to the standard indications for …
-
FDA approval · 2009-03-23FDA Approved: RISPERIDONE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for Risperidone from Jubilant Cadista Pharmaceuticals Inc., enabling generic risperidone to be markete…
-
CLINICAL_TRIALS research · 2009-03-11Clinical Trial Update: Use of Pharmacogenetics in the Treatment of Children With Autistic Spectrum Disorders
An update on a pediatric pharmacogenetics trial for treating autism spectrum disorders, with the current study status not disclosed.
-
FDA approval · 2009-02-24FDA Approved: RISPERIDONE — Original Application (Amici Pharma, Inc.)
FDA approves the original application for a risperidone generic from Amici Pharma, Inc.
-
FDA approval · 2009-01-30FDA Approved: RISPERIDONE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' original application for risperidone, adding a generic version of the antipsychotic.
-
CLINICAL_TRIALS research · 2009-01-16Clinical Trial Update: Characterization of Executive Functions and Patterns of Eye Movements in Children With Developmental Disabilities
Clinical trial update describing methods to characterize executive functions and eye movement patterns in children with developmental disabi…
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Dimercaptosuccinic Acid (DMSA) Treatment of Children With Autism and Heavy Metal Toxicity [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluated dimercaptosuccinic acid (DMSA) for autism in children with heavy metal toxicity.
-
CLINICAL_TRIALS research · 2008-12-05Clinical Trial Update: Functional Behavioural Skill Training for Young Children With Severe Autism [NA]
An update on a clinical trial evaluating Functional Behavioural Skill Training for young children with autism; the study status is currently…
-
FDA approval · 2008-10-30FDA Approved: RISPERIDONE — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original application for risperidone, providing a generic version of the antipsychotic.
-
FDA approval · 2008-10-16FDA Approved: RISPERIDONE — Original Application (Zydus Lifesciences Limited)
FDA approved an original abbreviated new drug application for risperidone by Zydus Lifesciences Limited, enabling the sale of a generic risp…